This site is your destination for uncovering cutting-edge strategies to prevent and detect the "Four Horsemen of Death" - cardiovascular disease, cancer, neurodegenerative conditions, and metabolic dysfunction (also called diabetes). We'll dive deep into innovative diagnostics from pioneering startups that are either commercially available or nearing market launch. Our goal is to shine a light on the science and innovation fueling these transformative tools, which aim to identify these deadly diseases early enough for effective interventions that can dramatically extend healthspan. By staying ahead of the curve on the latest advancements in preventive and early-detection technologies, you'll be empowered to take proactive steps to safeguard your long-term health and vitality.
Subscribe to get full access to the newsletter and publication archives.
About Ram Krishnan
The grief from losing both my parents to untimely deaths was overwhelming and transformative. It was a turning point in my life, sparking a deep-seated desire to contribute, in my own way, to the field of healthcare. Driven by this newfound purpose, I searched for ways to participate in a healthcare startup, either through investment or operational involvement, where I could make a positive impact and honor their memory.
Along with Adam Rizika and Dr. Ganesh Shankar, Ram Krishnan co-founded CSF Biosciences, a seed-stage company committed to the development of diagnostic assays for primary and metastatic brain tumors using CSF (Cerebrospinal Fluid). The primary goal is to commercialize TetRS, a rapid and targeted qPCR, CSF-based genotyping assay that can detect primary and metastatic brain tumors within 80 minutes of obtaining a CSF specimen, while obviating a brain biopsy. The diagnostic assay was developed by Dr. Ganesh Shankar, a Mass General Brigham neurosurgeon.
Stay up-to-date
Never miss an update—every new post is sent directly to your email inbox. For a spam-free, ad-free reading experience, plus audio and community features, get the Substack app.
